SCHEMBL281962

SCHEMBL281962

CC(Br)CCCN1C(=O)C(=O)c2ccccc21

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.64
ALDH3A1 P30838 5/20 0.64
ALDH2 P05091 4/20 0.64
CES1 P23141 6/20 0.63
BCHE P06276 2/20 0.63
CDC25A P30304 1/20 0.62
PKM P14618 1/20 0.58
TGM2 P21980 1/20 0.54
PARK7 Q99497 1/20 0.54
TP53 P04637 1/20 0.50
AGTR1 P30556 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CHRM1 P11229 2/20 0.49
CHRM5 P08912 1/20 0.48
CHRM3 P20309 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11149709 0.91 CES1 (0.67) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL902525 0.83 MAOB (0.54) ALDH1A1MEN1KMT2A
SCHEMBL25119569 0.82 CES1 (0.85) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL578329 0.81 CES1 (0.71) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL25119255 0.81 CES1 (0.84) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL3019788 0.80 ALDH1A1 (0.90) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL28591995 0.80 CES1 (0.81) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL10679114 0.79 ALDH1A1 (0.64) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL19924204 0.79 CES1 (1.00) ALDH1A1ALDH3A1ALDH2CES1BCHE
SCHEMBL281625 0.78 ALDH1A1 (1.00) ALDH1A1ALDH3A1ALDH2CES1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428515-A1 Spiro-oxindole compounds and their uses as therapeutic agents Xenon Pharmaceuticals Inc. (CA) 2012-03-14 EP disclosed
EP-2073806-B1 USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2012-02-15 EP disclosed
EP-1888595-B1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2012-02-01 EP disclosed